Clinical Trial

Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated June 26, 2025 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
To observe the effect of stem cell infusion on the development of acute graft- versus-host disease (aGVHD) in patients with nonmalignant hematologic diseases after allogeneic peripheral blood hematopoietic stem cell transplantation (allo-PBSCT)
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-02-28.
Status change: Not Yet Recruiting → Recruiting 2025-06-23
Trial Details
NCT Number NCT06294691
Lead Sponsor Anhui Provincial Hospital
Conditions Acute Graft-versus-host Disease
Enrollment 198 participants
Start Date 2024-03-15
Primary Completion 2025-11-30 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-26